Status:
UNKNOWN
Antipsychotic Medicine and Metabolic Syndrome
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborating Sponsors:
University Hospital, Gentofte, Copenhagen
University of Copenhagen
Conditions:
Metabolic Syndrome
Eligibility:
MALE
18-45 years
Brief Summary
The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and a quality of life. The investigators expect, that ...
Detailed Description
The primary aim of this study is to investigate status of neuro-and enteroendocrine axes with focus on beta - cell function in relation to insulin resistance, lipid profile abnormalities and inflammat...
Eligibility Criteria
Inclusion
- gender : male
- age: 18-45
- treatment with minimum one Antipsychotic drug (AP)
- ethnicity: caucasians
- consent given to take part in the project
Exclusion
- One criteria is sufficient to exclude patients from the study:
- compliance problems
- unable to read, write and talk Danish
- patients with major lung-,heart-, lever- and kidney problems
- patients with diagnose and treatment for Diabetes 1 and 2
- patients taking cholesterol-reducing, weight-reducing and antihypertensive medication
- patients with abuse of alcohol or drugs
- patients who are under duress §
- patients who have been mentally ill for more than 15 years
- patients with diagnosis/treatment for NIDDM/IDDM
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00627757
Start Date
February 1 2008
End Date
December 1 2010
Last Update
July 30 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric University Center Glostrup
Copenhagen, Glostrup, Denmark, 2600
2
Psychiatric University Center Glostrup
Copenhagen, Glostrup, Denmark, 2600